Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)

Scandinavian ChemoTech AB Revenue

Scandinavian ChemoTech AB had revenue of 2.80M SEK in the quarter ending March 31, 2026, with 13.19% growth. This brings the company's revenue in the last twelve months to 12.61M, up 63.93% year-over-year. In the year 2025, Scandinavian ChemoTech AB had annual revenue of 12.29M with 87.10% growth.

• Revenue (ttm): 12.61M
• Revenue Growth: +63.93%
• P/S Ratio: 7.43
• Revenue / Employee: 12.61M
• Employees: 2
• Market Cap: 93.67M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	12.29M	5.72M	87.10%
Dec 31, 2024	6.57M	3.74M	132.67%
Dec 31, 2023	2.82M	2.35M	496.62%
Dec 31, 2022	473.00K	-2.11M	-81.70%
Dec 31, 2021	2.59M	1.17M	82.81%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error